As filed with the Securities and Exchange
Commission on August 29, 2000 Registration No. 333-31768
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------
Pre-Effective Amendment No. 2
to
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
----------------------------------
AREMISSOFT CORPORATION
(Exact name of the Company as specified in its charter)
Delaware 68-0413929
--------------------------------------------- ---------------------------------
(State or other jurisdiction of incorporation (I.R.S. Employer Identification
or organization) Number)
Goldsworth House
Denton Way
Woking, Surrey GU21 3LG
United Kingdom
Telephone: 011-44-1483-885-000
--------------------------------------------------------------
(Address, including zip code, and telephone number, including
area code, of Registrant's principal executive offices)
Roys Poyiadjis
President and Chief Executive Officer
AremisSoft Corporation
Sentry Office Plaza
216 Haddon Avenue, Suite 607
Westmont, New Jersey 08108
Telephone: 212-246-2141
Facsimile: 212-765-7385
--------------------------------------------------------------------------------
(Name, address, including zip code, and telephone number, including area code,
of agent for service of process)
Copies to:
Scott E. Bartel, Esq.
Eric J. Stiff, Esq.
Bartel Eng Linn & Schroder
300 Capitol Mall, Suite 1100
Sacramento, CA 95814
Telephone: 916-442-0400
Facsimile: 916-442-3442
-----------------------------
Approximate date of commencement of the proposed sale to the public: As soon as
practicable after the Registration Statement becomes effective.
If the only securities being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. [ ]
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement of the earlier effective registration statement for the
same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
<PAGE>ii
<TABLE>
<S> <C> <C> <C> <C>
CALCULATION OF REGISTRATION FEE
Proposed maximum
Title of each class of Amount to be offering price per Proposed maximum Amount of
securities to be registered registered share(1) aggregate offering price registration fee
--------------------------- ------------ ------------------- ------------------------- -------------------
Common Stock, 800,000 $27.41 $21,928,000 $5,789(2)
$0.001 par value
</TABLE>
(1) Estimated solely for the purpose of calculating the registration fee in
accordance with Rule 457(c) under the Securities Act of 1933, as amended,
based upon the average of the high and low prices reported on the Nasdaq
National Market on August 24, 2000.
(2) A registration fee in the amount of $35,465 was previously paid.
The registrant hereby amends this registration statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this registration
statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the registration statement shall become
effective on such date as the Commission, acting pursuant to said section 8(a),
may determine.
<PAGE>iii
The information in this prospectus is not complete and may be changed. We may
not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell these securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED AUGUST 29, 2000
PROSPECTUS
800,000 Shares
[AREMISSOFT LOGO]
Common Stock
----------------
By this prospectus, we may offer up to 800,000 shares of our common
stock. We will provide specific terms for the sale of the shares of common stock
in supplements to this prospectus. You should read this prospectus and any
supplement carefully before you invest.
This prospectus may not be used to offer and sell securities unless
accompanied by a prospectus supplement.
Our common stock is quoted on the Nasdaq National Market under the
symbol AREM. The last reported sale price of the shares of our common stock on
the Nasdaq National Market on August 24, 2000 was $27.00 per share.
----------------
Investing in the common stock involves a high degree of risk. See "Risk
Factors" beginning on page 3.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.
The date of this prospectus is August 29, 2000
<PAGE>iv
Table of Contents
Page
Prospectus Summary.......................................... 1
About This Prospectus....................................... 1
Where You Can Find More Information......................... 1
Forward Looking Statements.................................. 2
AremisSoft Corporation...................................... 3
Risk Factors................................................ 3
Use of Proceeds............................................. 11
Description of Capital Stock................................ 11
Plan of Distribution........................................ 14
Legal Matters............................................... 14
Experts..................................................... 14
<PAGE>1
PROSPECTUS SUMMARY
This summary highlights selected information from this prospectus and does
not contain all of the information that is important to you. To understand the
terms of the offering you should read carefully this prospectus with the
prospectus supplement. Together, these documents describe the specific terms of
the securities we are offering. You should also read the documents listed below
in "Where You Can Find More Information."
As used in this prospectus, the terms "we," "us," "our," and "AremisSoft"
mean AremisSoft Corporation and its subsidiaries, unless otherwise indicated.
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement on Form S-3 that we
filed with the Securities and Exchange Commission, or SEC, utilizing a "shelf"
registration process. Under this shelf process, we may, over the next two years,
sell up to 800,000 shares of our common stock in one or more offerings. This
prospectus provides you with a general description of the shares of common stock
we may offer. Each time we sell shares of our common stock we will provide a
prospectus supplement that will contain specific information about the terms of
that offering. The prospectus supplement may also add, update or change
information contained in this prospectus. You should read both the prospectus
and any prospectus supplement together with additional information described
below in "Where You Can Find More Information." The registration statement that
contains this prospectus also contains exhibits and additional information about
us and the securities offered under this prospectus. That registration statement
can be read at the SEC web site or at the SEC offices mentioned below in "Where
You Can Find More Information." We may only use this prospectus to sell
securities if it is accompanied by a prospectus supplement. We are only offering
these securities in states where the offer is permitted.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and special reports, proxy statements and other
information with the SEC. You may read any document we file at the SEC's public
reference facilities located at Room 1024, Judiciary Plaza, 450 Fifth Street,
N.W., Washington, D.C. 20549 and at the regional offices located at Seven World
Trade Center, 13th Floor, New York, New York 10048 and 500 West Madison Street,
Suite 1400, Chicago, Illinois 60661. Copies of such material, when filed, may
also be obtained from the SEC's Public Reference Section located at 450 Fifth
Street, N.W., Washington, D.C. 20549 at prescribed rates. Please call the SEC
toll free at 1-800-SEC-0330 for further information about its public reference
rooms. Our SEC filings are also available on the SEC's website at
"http://www.sec.gov."
As discussed above, we have filed with the SEC a registration statement on
Form S-3 under the Securities Act of 1933, as amended. This prospectus does not
contain all of the information in the registration statement. We have omitted
certain parts of the registration statement, as permitted by the rules and
regulations of the SEC. You may inspect and copy the registration statement,
including exhibits, at the SEC's public reference facilities or its website. Our
statements in this prospectus about the contents of any contract or other
document are not necessarily complete. You should refer to the copy of each
contract or other document that we have filed as an exhibit to the registration
statement for complete information.
The SEC allows us to "incorporate by reference" the information we filed
with them, which means that we can disclose important information by referring
you to those documents. The information incorporated by reference is considered
to be a part of this prospectus, and information that we file later with the SEC
will automatically update and supersede this information. We incorporate by
reference the documents listed below and any future filings made by us with
<PAGE>2
the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act until this
offering is completed:
- Annual Report on Form 10-K for the fiscal year ended December 31,
1999;
- Quarterly Report on Form 10-Q for the quarter ended March 31, 2000;
- Quarterly Report on Form 10-Q for the quarter ended June 30, 2000;
- Current Report on Form 8-K filed on December 30, 1999 (as amended on
Form 8-K/A filed on March 6, 2000); and
- The description of our common stock contained in Form 8-A filed with
the Commission on April 5, 1999, and any amendment or report filed for
the purpose of updating such description.
You may request a copy of these filings, other than exhibits, free of
charge, by writing or telephoning us at the following address:
AremisSoft Corporation
Sentry Office Plaza
216 Haddon Avenue, Suite 607
Westmont, New Jersey 08108
(856) 869-0770
You should rely only on the information incorporated by reference or
provided in this prospectus or any prospectus supplement. We have not authorized
anyone else to provide you with different information. We are not making an
offer of these securities in any state where the offer is not permitted. You
should not assume the information in this prospectus or any prospectus
supplement is accurate as of any date other than the date on the front of those
documents.
FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements, as that term is
defined in the Private Securities Litigation Reform Act of 1995. This Act
provides a "safe harbor" for forward-looking statements to encourage companies
to provide prospective information about themselves so long as they identify
these statements as forward-looking and provide meaningful cautionary statements
identifying important factors that could cause actual results to differ from the
projected results. All statements other than statements of historical fact we
make in this prospectus, prospectus supplement or in any document incorporated
by reference are forward-looking. In particular, that statements herein
regarding industry prospects and our future results of operations or financial
position are forward-looking statements. These statements relate to future
events or our future financial performance. In some cases, you can identify
forward- looking statements by terminology such as "may," "will," "should,"
"could," "expects," "plans," "anticipates," "believes," "estimates," "predicts,"
"potential" or "continue" or the negative of these terms or other comparable
terminology. These statements are only predictions and involve known and unknown
risks, uncertainties and other factors, including the risks outlined below in
"Risk Factors," that may cause our or our industry's actual results, levels of
activity, performance or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied by
these forward-looking statements.
Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results, levels of
activity, performance or achievements. Except as required by applicable law,
including the securities laws of the United States, we do not intend to update
any of the forward-looking statements after the date of this prospectus, any
prospectus supplement, or in any document incorporated by reference to conform
these statements to actual results.
<PAGE>3
AREMISSOFT CORPORATION
We develop, market, implement and support enterprise-wide software
applications primarily for mid-sized organizations in the manufacturing,
healthcare, hospitality and construction industries. Our fully integrated suite
of Internet-enabled products allows our customers to manage and execute
mission-critical functions within their organization, including accounting,
purchasing, manufacturing, customer service, and sales and marketing.
Our software applications use our internally developed three-tiered, object
oriented software architecture, which we call the Aremis architecture. This
architecture enables us to develop software solutions rapidly and cost-
effectively by taking advantage of the common requirements of customers in our
target markets. In addition, we believe that, with the developers based in our
facilities in India, we have established a cost-effective model for
implementing, supporting and enhancing our software applications.
Our objective is to be a leading provider of enterprise-wide software
applications for mid-sized organizations in the manufacturing, healthcare,
hospitality and construction industries. Our strategy for achieving this
objective includes:
o focusing on marketing to mid-sized organizations,
o further penetrating our target markets in the manufacturing,
healthcare, hospitality and construction industries,
o increasing efficiencies by using our software development facilities
based in India,
o providing Internet-enabled software solutions in response to our
customers' needs,
o expanding on our technological expertise, and
o expanding sales, marketing, support and service.
Our principal executive offices are located at Goldsworth House, Denton
Way, Woking, Surrey GU21 3LG, United Kingdom, and our telephone number is
011-44-1483-885-000.
RISK FACTORS
Investing in the shares of our common stock offered by this prospectus
involves a high degree of risk. You should carefully consider the risks
described below in addition to the other information in this prospectus and the
prospectus supplement. Our business, operating results and financial condition
could be seriously harmed due to any of the following risks. The trading price
of the shares of our common stock could decline due to any of these risks, and
you could lose all or part of your investment.
We have a history of losses and we could suffer losses in the future.
Until the second half of 1997, we incurred substantial losses. Our losses
were $1.6 million for 1997 and $15.3 million for 1996. As of December 31, 1999,
we had an accumulated deficit of $18.9 million.
Although we have operated profitability since the third quarter of 1997, we
cannot assure you that we will sustain profitability on a quarterly or annual
basis in the future. We expect to continue to incur increasing cost of revenues,
research and development, sales and marketing and general and administrative
expenses. If we are to continue to sustain profitability given our planned
expenditure levels, we will need to generate and sustain increased revenues.
Our quarterly operating results may fluctuate causing volatility, or
decline in the market price of our common stock.
<PAGE>4
Our revenues, gross margins and other operating results have fluctuated
significantly in the past and may vary significantly from quarter to quarter.
These fluctuations may be due to a number of factors, many of which are beyond
our control. These factors include:
o the relatively long sales cycles for our products,
o the size and timing of our licensing transactions,
o the timing of release, proper operation and market acceptance of our
rejuvenated products, product enhancements or new products,
o changes in the budget cycles of our customers,
o seasonality of our customers' technology purchases, and
o foreign currency exchange rates.
The timing of our revenue recognition can be affected by many factors,
including the timing of a contract's execution and delivery, a customer's
acceptance and our post-delivery obligations with respect to the installation
and implementation of our products. As a result, the time between contract
execution and the satisfaction of the criteria necessary for revenue recognition
can be lengthy and unpredictable and, consequently, may affect our revenues. As
a result, it is possible that in some future quarters our results of operations
may fall below the expectations of some securities analysts and investors. In
that event, the trading price of our stock may likely be materially and
adversely affected.
We may acquire other companies' products, technologies or businesses that
could be difficult to integrate, disrupt our business and dilute stockholder
value.
As part of our strategy, we expect to continue to pursue acquisitions of
other businesses, products and technologies. In connection with an acquisition,
we may pay cash, issue stock or incur debt. Our stockholders will be diluted if
we finance acquisitions by incurring convertible debt or issuing equity
securities. In addition, we may be required to incur expenses related to
goodwill and other intangible asset amortization.
Acquisitions of companies and businesses also involve numerous other risks,
including:
o difficulties in the assimilation of the operations, technologies,
products and personnel of the acquired business,
o diversion of our management's attention from other business concerns,
o risks of entering markets in which we have no or limited direct
experience, and
o the potential loss of key employees of the acquired business.
From 1993 through 1996, we acquired eleven companies with aggregate annual
revenues in the last fiscal year prior to acquisition of approximately $24.2
million and we recently acquired e-nnovations.com which had revenues of
approximately $3.1 million in 1999. Our acquisition strategy is focused on
acquisitions that are potentially larger in scope and size than any of our
previous acquisitions and we cannot assure you that we will successfully
integrate an acquisition of this size into our operations. Although we currently
have no agreement, understanding or arrangement with respect to any future
acquisitions, we continually evaluate acquisition opportunities. Any future
acquisition may also disrupt our ongoing business, divert the attention of our
management and employees from day to day operations and increase our operating
expenses.
<PAGE>5
Failure to manage our growth may seriously harm our ability to deliver
products in a timely manner, fulfill existing customer commitments and attract
and retain new customers.
We have grown rapidly in the last five years, with total revenues
increasing from $21.4 million in 1995 to $73.4 million in 1999. Our growth has
placed a significant strain on our management, operations and financial
resources. Our recent expansion has resulted in substantial growth in the number
of our employees, the scope of our operating and financial reporting systems and
the geographic area of our operations. This growth has placed, and will continue
to place, a significant strain on our managerial, operational and financial
resources. Accordingly, our future operating results will depend on our ability
to continue to implement and improve our operational and customer support
systems and to expand, train and manage our employee base. We cannot assure you
that we will be able to manage our expansion successfully, and our inability to
do so may seriously harm our ability to deliver products in a timely manner,
fulfill existing customer commitments and attract and retain new customers.
We must successfully develop new products and keep pace with rapid
technological change to remain competitive.
The market for our products is characterized by rapid technological
changes, evolving industry standards in computer hardware and software
technology, changes in customer requirements and frequent new product
introductions and enhancements. Our future success will depend upon our ability
to continue to enhance our current product line and to develop and introduce new
products that keep pace with technological developments, satisfy increasingly
sophisticated customer requirements and achieve market acceptance. We cannot
assure you that we will be successful in developing and marketing, on a timely
and cost-effective basis, fully functional product enhancements or new products
that respond to technological advances by others. We can also not assure you
that our new or enhanced products will achieve market acceptance. Our customers
utilize a wide variety of hardware, software, database and networking platforms.
As a result, we must continue to support and maintain our products on a variety
of these platforms. In particular, we must continue to anticipate and respond
adequately to advances in other software and desktop computer operating systems
like Microsoft Windows.
We may not succeed in penetrating the e-business and application service
provider markets.
We may not have the resources, skills and product offerings that will be
required to successfully penetrate the e-business and application service
provider markets. To succeed in these markets, we must continue to:
o develop expertise in marketing and selling Internet-based applications
and services,
o develop and cultivate new sales channels to market our applications to
prospective customers,
and
o hire, train and integrate new technical and sales personnel.
The e-business and application service provider markets that we may attempt
to penetrate may not become substantial commercial markets for our applications
or may not evolve in a manner that will enable our applications to achieve broad
market acceptance.
<PAGE>6
Undetected errors may increase our costs and impair the market acceptance
of our products and technology.
Our products and technology have occasionally contained, and may in the
future contain, undetected errors when first introduced or when new versions are
released. Our customers integrate our products and technology into systems and
products that they develop themselves or acquire from other vendors. As a
result, when problems occur in equipment or a system into which our products or
technology have been incorporated, it may be difficult to identify their cause.
Regardless of the source of these errors, we must divert the attention of our
engineering personnel from our research and development efforts to address the
errors. We cannot assure you that we will not incur warranty or repair costs, be
subject to liability claims for damages related to product errors or experience
delays as a result of these errors in the future. Any insurance policies that we
have may not provide sufficient protection should a claim be asserted. Moreover,
the occurrence of errors, whether caused by our products or technology or the
products of another vendor, may result in significant customer relations
problems and injury to our reputation and may impair the market acceptance of
our products and technology.
We may be subject to product liability claims from product defects, which
may harm our operating results.
If our products malfunction or suffer from design defects, we may also be
subject to product liability claims. Our license agreements with our customers
typically contain provisions designed to limit our exposure to liabilities
arising from product liability claims. We also maintain errors and omissions
liability insurance in the amount of $6.0 million for damages as a result of
product defects or errors. However, we cannot assure you that the provisions in
our license agreements limiting our liability will be enforceable under
international, federal, state or local laws and judicial decisions or that our
insurance coverage will be sufficient to cover all losses resulting from product
defects or errors. To the extent our insurance is insufficient to cover any
losses we may incur, our operating results will suffer.
Competition in the markets for our products and technology is intense. We
may not be able to compete effectively in these markets and we may lose market
share to our competitors.
The markets for our enterprise-wide software applications are intensely
competitive and we expect competition to intensify in the future. We may not be
able to compete effectively in these markets and we may lose market share to our
competitors. Our principal competitors for products sold to customers in the
manufacturing industry include Epicor, Fourth Shift, QAD and Symix. We also
believe that large enterprise software vendors, like Baan, Oracle, PeopleSoft
and SAP, are increasing their marketing efforts to mid-sized organizations in
the manufacturing industry. In the healthcare industry, our principal
competitors include EMIS, GPASS, In Practice and TOREX. In the hospitality
industry, our principal competitors are Innsite and MICROS Systems. In the
construction industry, our competitors include Database, Estimation and FCG
Computer Systems. In addition, we face indirect competition from suppliers of
customized enterprise-wide software applications with highly customized software
and from the internal information technology departments of large organizations
who develop their own systems.
Many of our competitors have greater resources than we do. This may limit
our ability to compete effectively and may discourage customers from purchasing
our products.
Many of our competitors have greater financial, personnel and other
resources than we do, which may limit our ability to compete effectively. These
competitors may be able to respond more quickly to new or emerging technologies
or changes in customer requirements. These competitors may also:
o benefit from greater economies of scale,
o benefit from longer operating histories and name recognition,
<PAGE>7
o offer more aggressive pricing, and
o devote greater resources to the promotion of their products.
Any of these advantages may discourage customers from purchasing our
products. If we are unable to compete successfully against our existing or
potential competitors, our revenues and margins will decline.
We face a risk from increased competition as a result of acquisitions of
competitors by large software companies.
We believe the fragmented nature of the enterprise-wide software
applications market will result in future acquisitions of competitors by large
software companies or strategic alliances, which will lead to significant
consolidation in our industry. As a result, we may face an increase in
competition from larger companies and new entrants to the industry which could
harm our business and cause our stock price to decline.
Our ability to acquire complementary businesses and products may be harmed
by the increasing consolidation in our markets.
Increasing consolidation in our markets may require us to compete with
other software companies for strategic acquisition opportunities. We have
acquired complementary businesses and products in the past and we expect to
continue to pursue similar opportunities in the future. As competition in our
markets has increased, a number of our competitors have been acquired or have
entered into strategic alliances. A continuation of this trend may require us to
compete with other software companies for attractive acquisition opportunities
and may lead to fewer opportunities and increased acquisition costs which will
harm our acquisition strategy.
Our lengthy sales and implementation cycles may cause fluctuations in our
operating results, which could cause our stock price to decline.
Sales of our products require an extensive marketing effort because
decisions to purchase these products generally involve the evaluation of the
product by a significant number of a potential customer's personnel in various
functional and geographic areas. Our products are generally used for division-
or enterprise-wide purposes and involve significant capital outlays by customers
and relatively complex installations. Potential customers generally commit
significant resources to evaluate available enterprise-wide software
applications and require us to provide a significant level of education about
the use and benefits of our products. As a result, our sales cycle averages
between one and 12 months from initial contact to execution of a license
agreement. Our ability to forecast the timing and amount of specific sales is
limited, and the delay or failure to complete one or more large license
transactions could cause our operating results to fall below the expectations of
securities analysts and investors and cause our stock price to decline.
We are dependent on our key personnel, particularly Dr. Lycourgos K.
Kyprianou, our founder and chairman of the board. Any loss of the services of
our key personnel would harm our business.
Our future success depends to a large extent on the continued services of
our senior management and key personnel. In particular, we are highly dependent
on the services of Dr. Lycourgos K. Kyprianou, our founder and chairman of the
board. If we were to lose the services of Dr. Kyprianou or other key personnel,
our ability to manage operations and generate revenues would be harmed.
<PAGE>8
Our failure to retain and attract qualified personnel could harm our
business.
Our products require sophisticated research and development, sales and
marketing, and technical customer support. Our success depends on our ability to
attract, train and retain qualified personnel in each of these areas.
Competition for personnel in all of these areas is intense and we may not be
able to hire sufficient personnel to achieve our goals or support the
anticipated growth in our business. The market for the highly-trained personnel
we require is very competitive, due to the limited number of people available
with the necessary technical skills and understanding of our products and
technology. If we fail to attract and retain qualified personnel, our business
will suffer.
Our limited ability to protect our intellectual property and proprietary
rights may harm our competitiveness.
Our success is substantially dependent upon the protection of our
internally developed technology, including our Aremis architecture. Our
profitability could suffer if third parties infringe upon our intellectual
property rights or misappropriate our technology and other assets. To protect
our rights to our intellectual property, we rely on the protection provided by
applicable copyright, trademark and trade secret laws, confidentiality
procedures and licensing arrangements to establish and protect our proprietary
rights. We have a trademark application pending, but do not currently hold any
patents or registered copyrights. Despite our efforts, it may be possible for
unauthorized third parties to copy portions of our products or reverse engineer
or obtain and use information that we regard as proprietary. Policing
unauthorized use of our software is difficult and, while we are unable to
determine the extent to which piracy of our products exists, software piracy can
be expected to be a problem. In addition, the laws of some countries, including
India and the United Kingdom, do not protect our proprietary rights to the same
extent as do the laws of the United States. Any failure by us to protect our
intellectual property could result in competitors offering products
incorporating the same or similar technology which could reduce demand for our
products. Further, litigation to enforce our intellectual property rights, to
protect our trade secrets or to determine the validity and scope of the
proprietary rights of others could result in substantial costs and diversion of
resources.
Our products may infringe on the intellectual property rights of others,
which could increase our costs and negatively affect our profitability.
We expect that enterprise-wide software applications will increasingly be
subject to claims of infringement relating to software codes as the number of
products and competitors in our industry segment grows and the functionality of
products overlaps. We do not currently have liability insurance to protect
against the risk of third party intellectual property infringement claims. Any
claim, with or without merit and whether or not insured against, could be
time-consuming, result in costly litigation and require us to enter into royalty
and licensing agreements. These royalty or licensing agreements, if required,
might not be available on terms that are acceptable to us. An infringement
claim, even if not meritorious, could result in the expenditure of significant
resources and could negatively affect our profitability.
We occasionally enter into fixed price service contracts, which may lead to
lower margins and harm our operating results.
We offer a combination of enterprise-wide software applications,
implementation and support services to our customers. We have, from time to
time, entered into fixed-price service contracts that require us to provide
support services for a fixed price regardless of our actual costs incurred in
fulfilling our support service obligations. Revenues attributable to fixed-price
service contracts were approximately 11% of our total revenues for 1997,
approximately 11% of our total revenues for 1998 and approximately 14% of our
total revenues for 1999. Our inability to successfully complete these contracts,
as budgeted, could lead to lower operating margins and reduced revenues and
profits.
Our results of operations may be adversely impacted by currency
fluctuations.
<PAGE>9
We currently have operations in Argentina, Bulgaria, Germany, India,
Ireland, Mexico, the United Kingdom and the United States and independent
distributors in 14 additional countries. A significant portion of our revenues
is received in currencies other than the United States dollar, primarily in the
British pound. We also anticipate receiving substantial future payments in
Bulgarian Leva relating to our work with the Bulgarian National Health Insurance
Fund and other customers in Bulgaria. Because our financial statements are
reported in United States dollars, fluctuations of the British pound and other
currencies against the United States dollar have caused, and will continue to
cause, us to recognize foreign currency transaction gains or losses, which may
be material to our operations and impact our reported financial condition and
results of operations.
We face risks associated with doing business in international markets.
Our principal executive offices are located in the United Kingdom. Revenues
from our operations outside of the United States accounted for approximately 97%
of our total revenues in 1999. We expect that a significant portion of revenues
for the foreseeable future will be derived outside the United States. We are
subject to risks inherent in international business activities, including:
o difficulties in collecting accounts receivable and longer collection
periods,
o changing and conflicting regulatory requirements,
o potentially adverse tax consequences,
o tariffs and general export restrictions,
o difficulties in staffing and managing foreign operations,
o political instability,
o reduced protection for intellectual property rights in some countries,
and
o fluctuations in currency exchange rates.
The tax benefits that we currently receive in India may be lost if we fail
to satisfy specified conditions.
We maintain development and support facilities in New Delhi and Bangalore,
India. As of June 30, 2000, we had approximately 40% of our workforce in India.
As a means of encouraging foreign investment, the Indian government provides tax
incentives and exemptions from regulatory restrictions. Among the benefits that
directly affect us are tax holidays (temporary exemptions from taxation on
operating income) and liberalized import and export duties. The current tax
holiday to which we are entitled expires in March 2001. To be eligible for these
tax benefits, we must continue to meet specified conditions including continuing
to operate in a qualified software technology park and exporting sales of at
least 75% of our inventory turnover. Our failure to meet these conditions could
result in cancellation of the benefits or a requirement to pay damages in an
amount as later determined by the Indian government and customs duty on plant,
machinery, equipment, raw materials, components and consumables. In addition,
goods, raw materials and components for production imported by our offices in
India are generally exempt from the levy of a customs duty. These tax benefits
could be discontinued or modified in the future which could significantly harm
our operations in India.
<PAGE>10
Our operating results may be harmed by changing conditions in India.
Although wage costs in India are significantly lower than in the United
States, the United Kingdom and similar markets for comparably skilled software
engineering and other technical personnel, wages in India are increasing at a
faster rate than in the United States and the United Kingdom. In the past, India
has experienced significant inflation and shortages of foreign exchange, and has
been subject to civil unrest and acts of terrorism. Although the effect of
inflation on our financial statements for the periods discussed in this
prospectus has been insignificant, increases in inflation in the future or
changes in interest rates, taxation or other social, political, economic or
diplomatic developments could harm our operating results.
Our products for the healthcare industry are subject to government
regulations and specifications that can be difficult to satisfy. Our efforts to
satisfy these regulations and specifications may cause the prices of our
products to increase substantially, which may adversely affect sales.
Our products designed for the healthcare industry in the United Kingdom are
regulated by the National Health Service, a governmental agency commonly
referred to as the NHS, through a product accreditation procedure. While our
healthcare products currently meet NHS specifications for information systems,
these requirements are expected to be updated pursuant to the NHS' new
Information Management and Technology Strategy. The new mandatory specifications
are expected to require that all information technology systems in the United
Kingdom's healthcare marketplace conform with one another. Although we are
currently modifying our healthcare industry products in anticipation of the
proposed specifications, we may not meet all of these specifications or, if we
meet them, our related costs may be substantial and make the cost of our
healthcare products prohibitive for our customers. In addition, we have
experienced and expect to continue to experience a decrease in purchases of our
existing healthcare products as organizations in the healthcare industry in the
United Kingdom postpone purchases pending release of final regulations and
specifications. These regulations and specifications, as well as future changes
to NHS specifications for information systems, could harm our revenues from
healthcare related products.
It may be difficult to enforce a U.S. judgment against us, our officers and
directors and some of the experts named in this prospectus, or to assert U.S.
securities laws claims in the United Kingdom and to serve process on
substantially all of our officers and directors and these experts.
A majority of our directors, all of our executive officers and some of the
experts named in this prospectus are nonresidents of the United States. A
substantial portion of our assets and all or a substantial portion of the assets
of these officers and experts are located outside of the United States. As a
result, it may be difficult to effect service of process within the United
States with respect to matters arising under the United States securities laws
or to enforce, in United States courts, judgments predicated upon civil
liability under U.S. securities laws. It also may be difficult to enforce in the
United Kingdom, in original actions or in actions for enforcement of judgments
of U.S. courts, civil liabilities predicated upon U.S. securities laws.
Dr. Kyprianou owns a large percentage of our voting stock and has
significant influence over matters requiring shareholder approval, which could
delay or prevent a change of control.
As of August 24, 2000, Dr. Kyprianou beneficially owned approximately 48.9%
of our outstanding common stock. In connection with the private placement with
Info-quest, an information technology company listed on the Athens Stock
Exchange, Dr. Kyprianou and Info-quest entered into a voting agreement. As a
result of the voting agreement, Dr. Kyprianou's beneficial ownership includes
shares held by Info-quest. The voting agreement requires Dr. Kyprianou to vote
his shares to elect board representatives of Info-quest and Info-quest is
similarly required to vote its shares for the board representatives nominated by
our board of directors. In addition, the agreement provides that each of Dr.
Kyprianou and Info-quest vote their shares by mutual agreement on all other
matters. As a result, these stockholders may, as a practical matter, be able to
substantially influence all matters requiring stockholder approval which could
delay or prevent a change of control.
<PAGE>11
Our common stock price has been volatile in the past and may be volatile in the
future.
The market price of our common stock is highly volatile and may be subject
to significant fluctuations in response to actual or anticipated variations in
quarterly operating results and other factors. From the time of our initial
public offering through August 24, 2000, the closing price of our common stock
reported on the Nasdaq National Market has ranged from $3 7/8 to $46 1/8 per
share. In addition, the stock market in general, and the market for technology
related stocks in particular, has experienced extreme volatility that often has
been unrelated to the operating performance of particular companies. These broad
market and industry fluctuations may adversely affect the trading price of our
common stock, regardless of our actual operating performance.
Provisions of our corporate documents and Delaware law could deter takeovers
which may prevent you from receiving a premium for your shares.
Provisions of our certificate of incorporation, bylaws and Delaware law
could delay, defer or prevent a change in our control. Our board of directors
has the authority to issue up to 15,000,000 shares of preferred stock and to fix
the rights, preferences, privileges and restrictions of those shares, including
voting rights, without any further vote or action by the stockholders. The
rights of our common stockholders could be adversely affected by the rights of
preferred stockholders in the future. In addition, we are subject to the
anti-takeover provisions of Section 203 of the Delaware General Corporation Law,
which prohibits us from engaging in a "business combination" with an "interested
stockholder" for a period of three years after the date of the transaction in
which the person became an interested stockholder, unless the business
combination is approved in a prescribed manner under Delaware law. The ability
of our board of directors to issue shares of preferred stock without further
stockholder approval, as well as the anti-takeover provisions of Delaware law,
could have the effect of delaying, deferring or preventing a change in control,
even if doing so would be beneficial to our stockholders.
We do not expect to pay dividends.
We have never declared or paid any cash dividends on our common stock. We
currently expect to retain our future earnings for use in the operation and
expansion of our business and do not anticipate paying any cash dividends in the
foreseeable future.
USE OF PROCEEDS
Unless otherwise indicated in the applicable prospectus supplement, we
expect to use the net proceeds from the sale of our common stock being offered
herein for working capital and other general corporate purposes and capital
expenditures. We may also apply a portion of the net proceeds to acquire or
invest in businesses, products or technologies that complement ours. We have no
present plans, agreements or arrangements with respect to any acquisitions or
investments. Pending these uses, we will invest the net proceeds in government
securities and other short-term, investment-grade, interest-bearing instruments.
DESCRIPTION OF CAPITAL STOCK
General
Our certificate of incorporation provides for authorized capital stock of
100,000,000 shares, consisting of 85,000,000 shares of common stock, $.001 par
value per share, and 15,000,000 shares of preferred stock, $.001 par value per
share.
<PAGE>12
Common Stock
The holders of common stock are entitled to one vote for each share held of
record on all matters submitted to a vote of the stockholders and do not have
preemptive rights. Our certificate of incorporation does not provide for
cumulative voting for the election of directors. Subject to preferences that may
be applicable to any then outstanding preferred stock, holders of common stock
are entitled to receive ratably such dividends, if any, as may be declared by
the board of directors out of funds legally available therefor. All outstanding
shares of common stock are, and the common stock to be outstanding upon
completion of this offering will be, fully paid and nonassessable. In the event
of any liquidation, dissolution or winding up of our affairs, the holders of
common stock will be entitled to share ratably in our assets remaining after the
payment or provision for payment of all of our debts and obligations and
liquidation payments to holders of outstanding shares of preferred stock.
Holders of common stock have no preemptive or conversion rights or other
subscription rights and there are no redemption or sinking fund provisions
applicable to the common stock.
Preferred Stock
Our certificate of incorporation authorizes 15,000,000 shares of
undesignated preferred stock. The board of directors has the authority, without
further action by the stockholders, to issue from time to time the preferred
stock in one or more series and to fix the number of shares, designations,
preferences, powers and relative participating, optional or other special rights
and the qualifications or restrictions thereof. The preferences, powers, rights
and restrictions of different series of preferred stock may differ with respect
to dividend rates, amounts payable on liquidation, voting rights, conversion
rights, redemption provisions, sinking fund provisions and other matters. The
issuance of preferred stock could reduce the amount of earnings and assets
available for distribution to holders of common stock or affect adversely the
rights and powers, including voting rights, of the holders of common stock, and
may have the effect of delaying, deferring or preventing a change in control. We
have no present plan to issue any shares of preferred stock.
Anti-Takeover Effects of Provisions of Our Certificate of Incorporation, Bylaws
and Delaware Law
Provisions of our certificate of incorporation and bylaws summarized in the
following paragraphs may have the effect of discouraging a future takeover
attempt that is not approved by our board of directors but that individual
stockholders may deem to be in their best interests or by which stockholders may
receive a substantial premium for their shares over then current market prices.
As a result, stockholders who might desire to participate in such a transaction
may not have an opportunity to do so. Such provisions will also make the removal
of our board of directors or management more difficult.
Preferred Stock
Our board of directors has the authority to authorize issuance of shares of
preferred stock and to determine the terms of any one or more series of
preferred stock, including voting rights, conversion rates and liquidation
preferences. As a result of the ability to fix voting rights for a series of
preferred stock, our board of directors has the power, consistent with its
fiduciary duty, to issue a series of preferred stock to persons friendly to
management in order to attempt to block a merger or other transaction by which a
third party seeks control, and thereby assist management in retaining our
position.
Advance Notice Provisions for Stockholder Proposals and Stockholder Nominations
of Directors
Our bylaws require that a stockholder give no fewer than 60 nor greater
than 90 days advance written notice with regard to the nomination of candidates
for election as directors and with regard to other matters to be brought before
our annual meeting of stockholders. Although our bylaws do not give the board of
directors any power to approve or disapprove stockholder nominations for the
election of directors or of any other business desired by stockholders to be
conducted at an annual or any other meeting, our bylaws may have the effect of
precluding a nomination for the election of directors or precluding the conduct
of business at a particular annual meeting if the proper procedures are not
followed which may also discourage or deter a third party from conducting a
solicitation of proxies to elect its own slate of directors or otherwise
<PAGE>13
attempt to obtain control, even if the conduct of the solicitation or attempt
might be beneficial to us and our stockholders.
Delaware Law
We are subject to Section 203 of the Delaware General Corporation Law that
generally prohibits a Delaware corporation from engaging in any of a broad range
of business combinations with any interested stockholder, as defined below, for
a period of three years following the time that the stockholder became an
interested stockholder, unless:
o before that time, the board of directors of the corporation approved
either the business combination or the transaction which resulted in
the stockholder becoming an interested stockholder,
o upon consummation of the transaction which resulted in the stockholder
becoming an interested stockholder, the interested stockholder owned
at least 85% of the voting stock of the corporation outstanding at the
time the transaction commenced, excluding for purposes of determining
the number of shares outstanding those shares owned by persons who are
directors and officers and by employee stock plans in which employee
participants do not have the right to determine confidentially whether
shares held subject to the plan will be tendered in a tender or
exchange offer, or
o at or after such time, the business combination is approved by the
board of directors and authorized at an annual or special meeting of
stockholders, and not by written consent, by the affirmative vote of
at least 66 2/3% of the outstanding voting stock which is not owned by
the interested stockholder.
For purposes of Section 203 of the Delaware General Corporation Law, an
"interested stockholder" is defined as any person that is:
o the owner of 15% or more of the outstanding voting stock of the
corporation, or
o an affiliate or associate of the corporation who was the owner of 15%
or more of the outstanding voting stock of the corporation at any time
within the three-year period immediately prior to the date on which it
is sought to be determined whether such person is an interested
stockholder.
Section 203 of the Delaware General Corporation Law may have the effect of
delaying, deterring or preventing a change in control without further action by
our stockholders.
PLAN OF DISTRIBUTION
We may sell all or a portion of the common stock:
- through one or more underwriters or dealers for public offering and
sale,
- directly to investors,
- through agents, or
- through a block trade in which the broker or dealer engaged to handle
the block trade will attempt to sell the common stock as agent, but
may position and resell a portion of the block as principal to
facilitate the transaction.
We may distribute the common stock from time to time in one or more
transactions at a fixed price or prices, which may be changed from time to time:
<PAGE>14
- at market prices prevailing at the times of sale,
- at prices related to such prevailing market prices, or
- at negotiated prices.
We will describe the method of distribution of the common stock in the
prospectus supplement. Underwriters, dealers or agents may receive compensation
in the form of discounts, concessions or commissions from us or our purchasers,
as their agents in connection with the sale of the common stock. These
underwriters, dealers or agents may be considered to be underwriters under the
Securities Act. As a result, discounts, commissions, or profits on resale
received by the underwriters, dealers or agents may be treated as underwriting
discounts and commissions. In the prospectus supplement we will identify any
such underwriter, dealer or agent, and describe any compensation received by
them from us. Any initial public offering price and any discounts or concessions
allowed or reallowed or paid to dealers may be changed from time to time.
Underwriters, dealers and agents may be entitled to indemnification by us
against certain civil liabilities, including liabilities under the Securities
Act. Underwriters, dealers and agents also may be entitled to contribution with
respect to payments made by the underwriters, dealers or agents, under
agreements between us and the underwriters, dealers and agents.
We may grant underwriters who participate in the distribution of the common
stock an option to purchase additional shares of common stock to cover
over-allotments, if any, in connection with the distribution.
Underwriters or agents and their associates may be customers of, engage in
transactions with or perform services for us in the ordinary course of business.
LEGAL MATTERS
The validity of the issuance of the shares of common stock offered by this
prospectus will be passed upon for us by Bartel Eng Linn & Schroder, Sacramento,
California.
EXPERTS
Our consolidated financial statements incorporated in this prospectus by
reference have been so incorporated in reliance on the authority of Pannell Kerr
Forster, chartered accountants, independent auditors, upon the authority of such
firm as experts in accounting and auditing.
<PAGE>15
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following table sets forth the costs and expenses payable by us in
connection with the issuance and distribution of the securities being registered
hereunder. All of the amounts shown are estimates, except for the SEC
registration fee.
SEC registration fee $ 5,789
Printing and engraving expenses 250,000
Accounting fees and expenses 200,000
Legal fees and expenses 250,000
Transfer agent and registrar fees 3,000
Miscellaneous 13,601
Total 722,390
Item 15. Indemnification of Directors and Officers.
Our certificate of incorporation contains provisions eliminating or
limiting director liability to us and our stockholders for monetary damages
arising from acts or omissions in the capacity as a director. The provisions do
not, however, eliminate the personal liability of a director for any breach of a
director's duty of loyalty to us or our stockholders, for acts or omissions not
in good faith or which involve intentional misconduct or a knowing violation of
law or for any transaction from which the director derived an improper personal
benefit. In addition, these provisions do not eliminate personal liability,
under a negligence standard, for violations of Delaware statutory provisions
concerning unlawful dividends or stock repurchases or redemptions. This
provision offers persons who serve on our board of directors protection against
awards of monetary damages resulting from breaches of their duty of care, except
as discussed above. As a result, our ability or our stockholders' ability to
successfully prosecute an action against a director for breach of his or her
duty of care is limited. However, the provision does not affect the availability
of equitable remedies such as an injunction or rescission based upon a
director's breach of his duty of care.
Our certificate of incorporation and bylaws also provide that we will
indemnify our directors and officers to the fullest extent permitted by
applicable law, subject to limited exceptions against liabilities arising by
reason of their status or services as an officer or director.
We have entered into separate indemnification agreements with our directors
and some of our officers that require us to, among other things, advance
expenses as a result of any proceeding against them and to which they could be
indemnified. We may, from time to time, agree to provide similar indemnification
to our employees and agents.
The employment agreements with Dr. Kyprianou and Mr. Poyiadjis also provide
that we will indemnify these individuals for any losses, costs, damages or
expenses incurred as a direct consequence of the discharge of their duties or by
reason of their status as our agents.
<PAGE>16
Item 16. Exhibits and Financial Statement Schedules.
Unless otherwise noted, the following exhibits are filed with this
registration statement.
(a) Exhibits.
2.1 Agreement of Merger between the Registrant and AremisSoft Corporation,
a Nevada corporation dated March 5, 1999(1)
2.2 Plan and Agreement of Reorganization between AremisSoft Corporation, a
Nevada corporation and LK Global Information Systems, B.V.(1)
2.3 Addendum to the Plan and Agreement of Reorganization between
AremisSoft Corporation, a Nevada corporation and LK Global Information
Systems, B.V.(1)
3.1 Certificate of Incorporation(1)
3.2 Bylaws(1)
4.1 Specimen Common Stock Certificate(1)
4.2 Form of Warrant to purchase Common Stock(1)
5.1 Opinion of Bartel Eng Linn & Schroder
23.1 Consent of Bartel Eng Linn & Schroder contained in Exhibit 5.1
23.2 Consent of Pannell Kerr Forster, chartered accountants
24.1 Power of Attorney (included on signature pages)(2)
27.1 Financial Data Schedule(2)
-----------
(1) Incorporated by reference to the Registrant's Registration Statement on
Form S-1 (No. 333-58351).
(2) Previously filed on Form S-1 (No. 333-31768).
Item 17. Undertakings.
The undersigned registrants hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(a) To include any prospectus required by section 10(a)(3) of the
Securities Act of 1933, as amended (the "Securities Act");
(b) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in
the aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the "Calculation of
Registration Fee" table in the effective registration statement;
<PAGE>17
(c) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement;
Provided, however, that clauses (a) and (b) do not apply if the information
required to be included in a post-effective amendment by such clauses is
contained in periodic reports filed with or furnished to the Securities and
Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of
the Securities Exchange Act of 1934 (the "Exchange Act") that are incorporated
by reference in the registration statement.
(2) That, for purposes of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof;
(3) To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of the
offering;
(4) That, for purposes of determining any liability under the Securities
Act, each filing of the registrant's annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act that is incorporated by reference in this
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof;
(5) That, for purposes of determining any liability under the Securities
Act, the information omitted from the form of prospectus filed as part of this
registration statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act shall be deemed to be part of this registration
statement as of the time it was declared effective; and
(6) That, for purposes of determining any liability under the Securities
Act, each post-effective amendment that contains a form of prospectus shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
Company pursuant to the foregoing provisions, or otherwise, the Company has been
advised that in the opinion of the Commission such indemnification is against
public policy as expressed in the Act and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than the
payment by the Company of expenses incurred or paid by a director, officer or
controlling person of the Company in the successful defense of any action, suit
or proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Company will, unless in the
opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
<PAGE>18
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in New York City, New York, on August 29, 2000.
AREMISSOFT CORPORATION,
a Delaware Corporation
/s/ ROYS POYIADJIS
------------------------------
Roys Poyiadjis,
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.
Signature Date
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
Dr. Lycourgos K. Kyprianou,
Chairman of the Board
/s/ ROYS POYIADJIS
-------------------------------------- August 29, 2000
Roys Poyiadjis,
President and Chief Executive Officer
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
Michael Tymvios,
Chief Financial Officer
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
Dann V. Angeloff,
Director
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
George H. Ellis,
Director
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
H. Tate Holt,
Director
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
Noel Voice,
Director
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
M.C. Mathews,
Director
<PAGE>19
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
Theodoros Fessas,
Director
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
George Papadopoulos,
Director
/s/ ROYS POYIADJIS *
-------------------------------------- August 29, 2000
John Malamas,
Director
* By power of attorney dated March 5, 2000
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description
2.1 Agreement of Merger between the Registrant and AremisSoft Corporation,
a Nevada corporation dated March 5, 1999(1)
2.2 Plan and Agreement of Reorganization between AremisSoft Corporation, a
Nevada corporation and LK Global Information Systems, B.V.(1)
2.3 Addendum to the Plan and Agreement of Reorganization between
AremisSoft Corporation, a Nevada corporation and LK Global Information
Systems, B.V.(1)
3.1 Certificate of Incorporation(1)
3.2 Bylaws(1)
4.1 Specimen Common Stock Certificate(1)
4.2 Form of Warrant to purchase Common Stock(1)
5.1 Opinion of Bartel Eng Linn & Schroder
23.1 Consent of Bartel Eng Linn & Schroder contained in Exhibit 5.1
23.2 Consent of Pannell Kerr Forster, chartered accountants
24.1 Power of Attorney (included on signature pages)(2)
27.1 Financial Data Schedule(2)
-----------
(1) Incorporated by reference to the Registrant's Registration Statement on
Form S-1 (No. 333-58351).
(2) Previously filed on Form S-1 (No. 333-31768).
